C4 Therapeutics, Inc. Proceeds from Warrant Exercises
C4 Therapeutics, Inc. (CCCC) reported Proceeds from Warrant Exercises of $2.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2026-08-11
- C4 Therapeutics, Inc. proceeds from warrant exercises for the quarter ending 2026-06-30 was $1.00K.
- C4 Therapeutics, Inc. proceeds from warrant exercises for the quarter ending 2026-03-31 was $1.00K.
- C4 Therapeutics, Inc. proceeds from warrant exercises for the quarter ending 2025-06-30 was $0.00.
- C4 Therapeutics, Inc. proceeds from warrant exercises for the quarter ending 2025-03-31 was $0.00.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 6 month |
|---|---|---|
| 2026-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $2.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $1.00K 10-Q · filed 2026-05-12 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $0.00 10-Q · filed 2026-08-11 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |